Showing results (31-40 of 75) with videos related to
Sort By:
Pageof 8
American Heart Journal Plus : Cardiology Research and Practice|March 29, 2024
Inflammatory hypothesis of atherogenesis: Will colchicine be added to the armamentarium in the prevention of coronary artery disease?Bahadir Simsek, Bugra Han Egeli, Atakan Selte, et al.Journal of Gastrointestinal Cancer|October 17, 2024
Elevated Urinary Levels of Fungal and Environmental Toxins in Patients with Pancreatic Ductal AdenocarcinomaVanessa I Rodriguez, Jamila Mammadova, Jennifer B Permuth, et al.Journal of Health Care for the Poor and Underserved|November 12, 2013
Prevalence of fracture and osteoporosis risk factors in American Indian and Alaska Native peopleTracy Frech, Khe-ni Ma, Elizabeth D Ferrucci, et al.International Journal of Rheumatology|September 16, 2011
Low-dose naltrexone for pruritus in systemic sclerosisTracy Frech, Kirsten Novak, Monica P Revelo, et al.Health and Quality of Life Outcomes|October 6, 2010
Valuation of scleroderma and psoriatic arthritis health states by the general publicDinesh Khanna, Tracy Frech, Puja P Khanna, et al.Arthritis Research & Therapy|September 5, 2019
A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcersVivek Nagaraja, Cathie Spino, Erica Bush, et al.Frontiers in Oncology|July 18, 2022
Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of ImmunityJamila Mammadova, Anna Redden, Rachel Cruz, et al.Cardio-Oncology (London, England)|May 10, 2025
Methylation-based biological age and cardiotoxicity risk in breast cancer patients treated with trastuzumabJamila Mammadova, Alicia Richards, Adriana Gonzalez-Torriente, et al.Frontiers in Immunology|September 25, 2018
Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?Cosimo Bruni, Tracy Frech, Mirko Manetti, et al.Arthritis Research & Therapy|February 25, 2014
Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label studyAvram Goldberg, Thomas Geppert, Elena Schiopu, et al.Pageof 8